Contact Us
About
Our Company
Management Team
Board of Directors
Scientific Advisors
Product Candidates
Overview
HONEDRA® (formerly CLBS12)
OLOGO™ (CLBS14)
CLBS16
CLBS119
CLBS201
Technology
Overview
CD34+ Cell Technology
Publications
Investors & News
Overview
Events
Press Releases
Media Coverage
Company Fact Sheet
Corporate Presentation
Analyst Coverage
SEC Filings
Corporate Governance
Disclosures
Stock Information
FAQs
Active Clinical Trials
FREEDOM (CLBS16)
HONEDRA® (formerly CLBS12)
In the Clinic: Caladrius Biosciences
July 20, 2017
BioWorld highlights Caladrius’ Sanford Project: T-Rex Study and upcoming milestones.